Skip to main content
Caplight Logo









UVera

UVera

Private
PolandHealthcare & Life Scienceshttps://uvera.eu

Last Round

Grant

Jul 30, 2020

Total Funding Raised

$2.94M

Company Overview

UVera operates in Healthcare & Life Sciences and is based in Poland. Its latest recorded funding round was a Grant round in July 2020.

UVera is a biotechnology company that develops natural, eco-friendly UV protection compounds for the cosmetics industry.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

UVera Comparables

Compare UVera with similar companies based on industry and business-model similarity.

UVera comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Seaspire Skincare
84%
Swedish Algae Factory
79%
CODIF Technologie Naturelle
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

UVera Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 30, 2020
GrantNov 13, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Magdalena Jander

CEO, co-founder

Founding Team

For institutional investors. Book with your work email.

UVera Investors

Notable investors and investment history

UVera investors
InvestorRounds
European Innovation CouncilGrant
EIT HealthGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Monthly visitors grew 113% MoM.

  • Feb 12, 2026

    Grew 50% QoQ, from 6 to 9 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

UVera Filings

Explore SEC and related filing metadata, where available.

UVera filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about UVera's valuation, stock price, and market status.

Is UVera a public or private company?

UVera is a private company.

What is the current stock price of UVera?

UVera is a private company, so its shares have no public market price. Caplight tracks UVera's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is UVera worth (valuation)?

Valuation information for UVera is not publicly available.

Can I buy UVera stock?

UVera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was UVera's last funding round?

UVera's most recent funding round was Grant on July 30, 2020.

Who are the main investors in UVera?

Key investors in UVera include European Innovation Council, EIT Health.

Will UVera IPO soon?

No public IPO plans have been announced for UVera.

How can I track UVera secondary market activity?

Caplight tracks bids, offers, and trades in UVera's shares on secondary markets.

Firmographic Details

HeadquartersPoland
Employee Range8
Year Founded2018
Last FundingJul 30, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?